Lead sponsor
Yonsei University
2 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
2
Trials led
2
Ongoing
120
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Not applicable
1
Trials by status
Not yet recruiting
1
Recruiting
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD PathologyAmyloid biomarker required (PET)N/ANot yet recruiting60